Genprex (GNPX) Stock: Reprogramming The Course Of Cancer
THE INTRO GENPREX, INC. (NASDAQ: GNPX) which is honoring its mission to REPROGRAMMING THE COURSE OF CANCER, is a clinical stage gene therapy approach company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogenic therapy for non-small cell lung cancer (NSCLC). Genprex’s novel … Read more